An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia

Indian Journal of Dermatology, Venereology and Leprology

Volumn 78, Issue 6, 2012, Pages 734-739

  Choon, Siew Eng ^a   Lai, Nai Ming ^b  

^a HOSPITAL SULTANAH AMINAH   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Allopurinol; carbamazepine; cotrimoxazole; drug eruptions; drug rash with eosinophilia and systemic symptoms; phenytoin; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; ANTIGOUT AGENT; CARBAMAZEPINE; COTRIMOXAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYTOIN;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CHINESE; CLINICAL FEATURE; DISEASE SEVERITY; DRESS SYNDROME; DRUG ERUPTION; DRUG FATALITY; DRUG MONITORING; ERYTHEMA MULTIFORME; ETHNIC DIFFERENCE; FEMALE; FIXED DRUG ERUPTION; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MORTALITY; PHOTODERMATOSIS; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; STEVENS JOHNSON SYNDROME; TERTIARY HEALTH CARE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GOUT SUPPRESSANTS; HUMANS; INCIDENCE; INFANT; MALAYSIA; MALE; MIDDLE AGED; PREVALENCE; STEVENS-JOHNSON SYNDROME; TERTIARY CARE CENTERS; TIME FACTORS; YOUNG ADULT;

EID: 84870230837     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.102367     Document Type: Article

References (19)

1. Arulmani R, Rajendran AD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2007;65:210-6.
2. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, et al. Cutaneous reactions to drug: An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839-46.
3. Bigby M, Jick S, Arndt K. Drug-induced cutaneous reactions: A report from the Boston Collaborative Drug Surveillance Programme on 15 438 consecutive inpatients, 1975-1982. JAMA 1986;256:3358-63.
4. Rahska M P, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol 2008;74:74-80.
5. Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003;149:1018-22.
6. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents: A 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95-9.
7. Borch JE, Andersen KE, Bindslev-Jensen C. Prevalence of acute cutaneous drug reactions in a University hospital. Acta Derm Venereol 2006;86:518-22.
8. Borch JE, Andersen KE, Bindslev-Jensen C. Cutaneous adverse drug reactions seen at a University hospital Department of Dermatology. Acta Derm Venereol 2006;86:523-7.
9. Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care centre in South India. Indian J Dermatol Venereol Leprol 2004;70:20-4.
10. Roujeau JC, Stern RS. Severe adverse reactions to drugs. N Eng J Med 1994;333:1272-85.
11. The use of the WHO-UMC system for standardised case causality assessment. Available from: http://who-umc.org/Graphics/24734.pdf. [Last accessed on 2012 Jan 26].
12. Huang HY, Luo XQ, Chan LS, Cao ZH, Sun X F, XU JH. Cutaneous adverse drug reactions in a hospital-based Chinese population. Clin Exp Dermatol 2011;36:135-41.
13. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A metaanalysis of prospective studies. JAMA 1998;279:1200-5.
14. Zaraa I, Jones M, Trojjet S, Rouhou RC, Euch DE, Mokni M, et al. Severe adverse cutaneous drug eruptions: Epidemiological and clinical features. Int J Dermatol 2011;50:877-80.
15. *1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review. Neurol Asia 2008;13:15-21.
16. * with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in a multiethnic Malaysian population. Int J Dermatol 2011;50:221-4.
17. Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital, Johor, Malaysia. Int J Dermatol 2010;49:834-41.
18. Halevy S, Ghislain PD, Mockenhaupt M, Fagot J P, Bavinck JNB, Sidoroff A, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008;58:25-32.
19. Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, et al. Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: A study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 2008;22:1044-9.